Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas

Abstract

Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) expression is often silenced in many types of human tumors. However, the relationship between RIZ1 expression and malignant meningiomas remains unclear. Here we have found for the first time that the expression of RIZ1 genes are associated with meningiomas progression through extensive analyses of Affymetrix GeneChip microarray data. Further validation methods for gene expression included quantitative PCR (qPCR), western blot and immunohistochemistry analysis, and these methods confirmed that RIZ1 is significantly downregulated in malignant meningioma tissues, as compared with benign meningiomas. In addition, malignant meningioma cells were stably transfected with ectogenic RIZ1 using Lentivirus-mediated transfection, and the transfections were followed by an in vitro 5-bromo-2-deoxyuridin incorporation assay, colony formation assay, cell cycle analysis, invasive analysis, apoptotic assay and western blot analysis. Our results demonstrate that the forced expression of RIZ1 in a malignant meningioma cell line inhibited cellular proliferation and arrested the cells in the G2/M phase of the cell cycle. We also confirmed that overexpression of RIZ1 may induce apoptosis of malignant meningioma cells. Furthermore, RIZ1 overexpression in malignant meningioma cells was associated with the downregulation of c-myc expression. These results from our study indicate that RIZ1 expression is significantly downregulated as the formation of meningiomas progressed, and suggest that RIZ1 may represent a promising candidate tumor suppressor gene that contributes to malignant meningiomas.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97–109.

    Article  Google Scholar 

  2. Glaholm J, Bloom HJ, Crow JH . The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys 1990; 18: 755–761.

    Article  CAS  Google Scholar 

  3. Goldsmith BJ, Wara WM, Wilson CB, Larson DA . Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994; 80: 195–201.

    Article  CAS  Google Scholar 

  4. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC . ‘Malignancy’ in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 1999; 85: 2046–2056.

    CAS  PubMed  Google Scholar 

  5. Ware ML, Larson DA, Sneed PK, Wara WW, McDermott MW . Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma. Neurosurgery 2004; 54: 55–63.

    Article  Google Scholar 

  6. Carling T, Kim KC, Yang XH, Gu J, Zhang XK, Huang S . A histone methyltransferase is required for maximal response to female sex hormones. Mol Cell Biol 2004; 24: 7032–7042.

    Article  CAS  Google Scholar 

  7. Buyse IM, Shao G, Huang S . The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein. Proc Natl Acad Sci USA 1995; 92: 4467–4471.

    Article  CAS  Google Scholar 

  8. Huang S, Shao G, Liu L . The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression. J Biol Chem 1998; 273: 15933–15939.

    Article  CAS  Google Scholar 

  9. Liu L, Shao G, Steele-Perkins G, Huang S . The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter. J Biol Chem 1997; 272: 2984–2991.

    Article  CAS  Google Scholar 

  10. Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000; 406: 593–599.

    Article  CAS  Google Scholar 

  11. Chadwick RB, Jiang GL, Bennington GA, Yuan B, Johnson CK, Stevens MW et al. Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. Proc Natl Acad Sci USA 2000; 97: 2662–2667.

    Article  CAS  Google Scholar 

  12. He L, Yu JX, Liu L, Buyse IM, Wang MS, Yang QC et al. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res 1998; 58: 4238–4244.

    CAS  Google Scholar 

  13. Jiang G, Liu L, Buyse IM, Simon D, Huang S . Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1. Int J Cancer 1999; 83: 541–546.

    Article  CAS  Google Scholar 

  14. Steele-Perkins G, Fang W, Yang XH, Van Gele M, Carling T, Gu J et al. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev 2001; 15: 2250–2262.

    Article  CAS  Google Scholar 

  15. Piao Z, Fang W, Malkhosyan S, Kim H, Horii A, Perucho M et al. Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability. Cancer Res 2000; 60: 4701–4704.

    CAS  PubMed  Google Scholar 

  16. Jiang GL, Huang S . Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite-unstable colorectal cancers. Cancer Res 2001; 61: 1796–1798.

    CAS  PubMed  Google Scholar 

  17. Tao Y, Wei Q, Xu Z, Bai R, Li Y, Luo C et al. Holistic and network analysis of meningioma pathogenesis and malignancy. Biofactors 2006; 28: 203–219.

    Article  CAS  Google Scholar 

  18. Rossi V, Staibano S, Abbondanza C, Pasquali D, De Rosa C, Mascolo M et al. Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2. J Cell Physiol 2009; 221: 771–777.

    Article  CAS  Google Scholar 

  19. Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 2010; 70: 2350–2358.

    Article  CAS  Google Scholar 

  20. Modha A, Gutin PH . Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 2005; 57: 538–550.

    Article  Google Scholar 

  21. Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 1997; 94: 14719–14724.

    Article  CAS  Google Scholar 

  22. Shadat NM, Koide N, Khuda, Dagvadorj J, Tumurkhuu G, Naiki Y et al. Retinoblastoma protein interacting zinc finger 1 (RIZ1) regulates the proliferation of monocytic leukemia cells via activation of p53. Cancer Invest 2001; 28: 806–812.

    Article  Google Scholar 

  23. Gazzerro P, Abbondanza C, D'Arcangelo A, Rossi M, Medici N, Moncharmont B et al. Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation. Exp Cell Res 2006; 312: 340–349.

    CAS  PubMed  Google Scholar 

  24. Lee WH . Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery 1990; 27: 389–395.

    Article  CAS  Google Scholar 

  25. Kim Y, Shintani S, Kohno Y, Zhang R, Wong DT . Cyclin G2 dysregulation in human oral cancer. Cancer Res 2004; 64: 8980–8986.

    Article  CAS  Google Scholar 

  26. Zhang X, Sun H, Danila DC, Johnson SR, Zhou Y, Swearingen B et al. Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab 2002; 87: 1262–1267.

    CAS  PubMed  Google Scholar 

  27. Wang J, Wang Q, Cui Y, Liu ZY, Zhao W, Wang CL et al. Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells. J Neurooncol 2012; 106: 473–484.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The meningioma cell line IOMM-Lee and CH157-MN were kindly provided by Professor Randy Jensen and Dr David Gillespie (Utah State University, USA). The research was supported by Shanghai Science and Technology Foundation of China: 08431900400 (Guohan Hu), Shanghai Science and Technology Foundation of China: 09411950900 (Jianchun Liao), Shanghai Science and Technology Youth Fund of China: 09ZR410000 (Huanhai Liu) and Natural Sciences Fund Project of Anhui Province, China: No. 11040606M212 (Chunlin Wang).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to J C Liao or G H Hu.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Z., Wang, J., Liu, H. et al. Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas. Oncogene 32, 1216–1222 (2013). https://doi.org/10.1038/onc.2012.155

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2012.155

Keywords

This article is cited by

Search

Quick links